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Knockdown of Brm and Baf170, Components
of Chromatin Remodeling Complex, Facilitates
Reprogramming of Somatic Cells
Zongliang Jiang,1 Yong Tang,1 Xueming Zhao,1 Mingyuan Zhang,1
David M. Donovan,2 and Xiuchun (Cindy) Tian1

The SWI/SNF (SWItch/Sucrose NonFermentable or BAF, Brg/Brahma-associated factors) complexes are
epigenetic modifiers of chromatin structure and undergo progressive changes in subunit composition during
cellular differentiation. For example, in embryonic stem cells, esBAF contains Brg1 and Baf155, while their
homologs, Brm and Baf170, are present in BAF of somatic cells. In this study, we sought to determine whether
Brm and Baf170 play any roles in induced pluripotent stem cell (iPSC) reprogramming by using shRNAmediated knockdown studies in the mouse model. We found that knocking down Brm during early, mid, and
late stages (days 3, 6, and 9 after initial iPSC induction) and knocking down Baf170 during late-stage (day 9)
reprogramming improve the numbers of iPSC colonies formed. We further showed that inhibition of these
somatic BAF components also promotes complete reprogramming of partially reprogrammed somatic cells
(pre-iPSCs). Finally, we found that the expression of Brm and Baf170 during reprogramming was regulated by
Jak/Stat3 activity. Taken together, these data suggest that inhibiting somatic BAF improves complete reprogramming by facilitating the activation of the pluripotency circuitry.

Introduction

I

nduced pluripotent stem cells (iPSCs) are embryonic
stem cell (ESC)-like cells reprogrammed using ectopic
transcription factors, Oct4, Sox2, Klf4, and c-Myc (OKSM)
[1,2]. However, transcription factor-mediated reprogramming is a slow and inefficient process achieved by overcoming a series of epigenetic barriers [3]. Acquisition of
induced pluripotency requires an intricate interplay among
specialized transcriptional circuitries, signaling pathways,
and chromatin remodeling. In addition to DNA and histone
modifications, ATP-dependent enzymes that remodel chromatin are important controllers of chromatin structure and
assembly and are major contributors to regulations of gene
expression [4,5].
The SWI/SNF (SWItch/Sucrose NonFermentable) [also
known as BAF (Brg/Brahma-associated factors)] complex
consists of at least 15 core subunits and has ATP-dependent
chromatin remodeling activity. It is essential for the formation of totipotent and pluripotent cells of early embryos
[6]. In addition, the BAF complex is the most frequently
mutated chromatin regulatory complex in human cancers
and thus their manipulation constitutes a major strategy for

tumor suppression [7]. The BAF complex participates in
numerous developmental transitions by changing its subunit
composition. For example, the BAF complex in ESCs, esBAF, has a unique subunit composition defined by the
presence of Brg, Baf155, and Baf60a and the absence of
their somatic cell homologs Brm, Baf170, and Baf60c [8].
Altering this subunit composition caused a reduction in selfrenewal and pluripotency in mouse ESCs (mESCs) [8]. In
addition, Baf250a is also essential for self-renewal and
pluripotency in mESCs [9,10]. It has been shown that the
mechanisms of maintaining ESC pluripotency by esBAF are
mediated by conditioning the genome for LIF/STAT3 signaling and by regulating the functions of the polycomb
complex [11]. Conversely, adding esBAF components to
fibroblasts facilitates their reprogramming to pluripotent
cells. For example, Brg1 and Baf155, combined with Oct4,
Sox2, Klf4, and c-Myc, synergistically increased reprogramming efficiency by enhancing the binding of Oct4 to
target promoters [12]. These data also suggest that specific
components of the BAF complex serve to facilitate the activation of the pluripotency circuitry.
Given the influence of epigenetic factors over reprogramming fate and the documented role of SWI/SNF
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complexes in pluripotency, we sought to test the roles of
somatic Brm and Baf170 in mouse iPSC generation through
shRNA-mediated knockdown studies. Using mouse embryonic fibroblasts (MEFs) harboring the green fluorescence
protein (GFP) driven by the Oct4 promoter (OG-MEFs), we
found that inhibiting components of the somatic BAF improve complete reprogramming by facilitating the activation
of the pluripotency circuitry.

Materials and Methods
Chemicals and protein expression constructs
Jak inhibitor I ( Jaki) and doxycycline were purchased
from EMD Millipore. Erk inhibitor PD0329501 and GSK3b
inhibitor CHIR99021 (CHIR) were obtained from SelleckChem. The vectors for pMXs-Oct4, Klf4, Sox2, and cMyc [1], pLKO.1-puro, pLKO.1-scramble shRNA control
[13], and retro- and lentiviral packaging constructs,
pUMVC, pCMV-VSV-G, and psPAX2 [14], were all purchased from Addgene. DNA oligos designed against the
mouse Brm and Baf170 cDNA (shBrm_1, shBrm_2, and
shBaf170_1, shBaf170_2) and scramble sequence (shCtl)
(Supplementary Table S1; Supplementary materials are
available online at http://www.liebertpub.com/scd) were
subcloned into pLKO.1-puro vector. All DNA subcloning
was performed using the standard restriction enzyme digestion or Infusion PCR Cloning Kit (Clontech) and expression constructs of shBrm and shBaf170 were verified by
DNA sequencing. The human embryonic kidney cell line,
293T, for viral packaging was obtained from Invitrogen.

Cell culture, viral preparation, and reprogramming
assay
OG-MEFs as well as MEFs from CD1 mice were generated from E13.5 embryos as described [15]. OG-MEFs
up to passage 4 were used for reprogramming. Briefly,
pMXs, pMCs-, or pLKO.1-constructs, together with packaging vectors, pUMVC (for retrovirus), psPAX2 (for lentivirus), and pCMV-VSV-G plasmids, were cotransfected
into 293T cells according to Addgene protocols. Retrovirus OKSM and lentiviral short hairpin RNA were collected 48 and 72 h after transfection. The iPSC induction
from OG-MEFs using viral OKSM and reprogramming
medium was conducted as described [15]. Briefly, OGMEFs were plated on six-well plates and transduced (day
0) with retroviral OKSM with 10 mg/mL polybrene
(American Bioanalytical). After 24 h of viral transduction
(day 1), cells were trypsinized and passaged onto two twowell plates preseeded with mitomycin C-treated CD1 MEF
feeders. Lentiviral shBrm and shBaf170 constructs were
then transduced to reprogrammed cells at different stages
after OKSM transduction according to the experiment
design (Supplementary Fig. S1A). Dox was added after
lentiviral shBrm and shBaf170 infection, and GFP + colonies were counted 3 weeks after OKSM transduction under
a Nikon fluorescence microscope. GFP+ iPSC colonies
were picked 3 weeks after retroviral transduction and expanded in 2i/LIF medium until passage 5 when further
characterization was conducted. The average size of colonies (areas; mean – SD) was measured by using the ImageJ software (http://imagej.nih.gov/ij/index.html).
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Somatic cells partially reprogrammed by transfection of
OKM (pre-iPSCs) were generated from our previous study
[16]. These cells have ESC colony morphology, but are GFP
negative. For complete reprogramming of pre-iPSCs to iPSCs,
shBrm and shBaf170 were transduced (day 0) and GFP+ colonies
were counted 10 days after transfection (Supplementary Fig.
S1B), and mRNA of these reprogrammed cells was also subjected for quantitative real-time reverse transcription-polymerase
chain reaction (qRT-PCR) analysis. shCtl constructs were
transduced to reprogrammed cells and pre-iPSCs as controls.
For Jak inhibition, OG-MEFs were reprogrammed by
OKSM and cultured with either DMSO control or a low
dosage (1 mM) of Jaki, starting on day 3 of reprogramming
(Supplementary Fig. S1A). mRNA of these cells was then
collected for gene expression analysis at day 18.

FACS analyses
Cells reprogrammed from pre-iPSCs were trypsinized and
flow cytometry analysis was performed using BD FACS ARIA
III. All data analyses were carried out using the FlowJo software.

Embryoid body formation
Established iPSC lines at passage 6 were grown on CD1
MEF feeders. After 2 days, the cells were trypsinized and
replated to the original plate for 2 h to allow MEFs to attach.
The iPSCs that remained in the medium were collected and
subsequently plated onto Petri dishes containing DMEM +
10% FBS (Invitrogen) without LIF. Upon 7 days of differentiation, embryoid bodies (EBs) formed and were transferred
to 0.1% gelatin-coated cell culture dishes (Invitrogen). The
cells were allowed to reattach and to continue differentiation
for another 7 days before proceeding for RNA extraction,
qRT-PCR, or immunostaining as described below.

Alkaline phosphatase staining and immunostaining
Alkaline phosphatase (AP) staining was performed using a
Vector Red Alkaline Phosphate Substrate Kit I (Vector Laboratories) according to the manufacturer’s instruction. For
immunostaining, cells were grown on 12-mm glass coverslips
(Fisher Scientific) in six-well plates containing CD1 MEFs as
feeders. Cells were fixed in 4% paraformaldehyde with 1%
sucrose in PBS for 15 min at room temperature. The cell
membranes were permeabilized with 0.5% TX-100 in PBS-T,
then incubated for 2 h at 37C in 5% donkey or goat serum
with mouse anti-SSEA1 IgM (1:100), rabbit anti-Sox2 IgG
(1:100), or rabbit anti-Nanog IgG (1:100) (all from Millipore), or
rabbit anti-Oct4 antibody (1:100; Santa Cruz), washed in PBS-T,
and then incubated with Alexa Fluor 594-conjugated donkey
anti-rabbit or goat anti-mouse secondary antibodies (1:500; Invitrogen). Cells incubated in serum without primary antibodies
were kept as negative controls and R1-ESCs were stained as
positive controls. After the washes, cells were counterstained
with DAPI and mounted under coverslips. Fluorescence images were taken using a Nikon fluorescence microscope.

Western blot analyses
OG-MEFs were transduced with lentiviral vector, shCtl,
shBrm, or shBaf170 and cultured in medium containing
10% FBS for 4 days. OG-MEFs, pre-iPSCs, iPSCs, and
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R1-ESCs were cultured as described above. Total cellular
proteins were extracted using RIPA buffer (Thermo Scientific) with 1 · proteinase and phosphatase inhibitors (Thermo
Scientific). Proteins were quantified with the Pierce BCA
Protein Assay Kit (Thermo Scientific) and subjected to 10%
SDS-PAGE gel electrophoresis using the BioRad minigel
system and subsequently transferred to PVDF membranes.
The blotted membranes were then blocked with 5%
nonfat dry milk in TBS-T and incubated with primary antibodies at 4C overnight. The antibodies used were as
follows: anti-Brm (1:1,000; Cell Signaling), anti-Baf170
(1:1,000; Cell Signaling), and anti-GAPDH (1:2,000; Abcam, Inc.). Membranes were then washed and blotted with
HRP-conjugated goat anti-mouse or goat anti-rabbit secondary antibodies (1:5,000; Santa Cruz). Blotting signals
were detected by chemiluminescence using Pierce ECL
western blot substrate (Thermo Scientific) and quantified by
ChemiDoc XRS + imaging system with Image Lab software (BIO-RAD).

Quantitative real-time reverse transcription–
polymerase chain reaction
Total RNA was extracted using the RNeasy Mini kit
(Qiagen) and reverse transcribed using the SuperScript III
Reverse Transcription Kit (Invitrogen). qRT-PCR was performed with specific primers (Supplementary Table S2)
using SYBR Green PCR Master Mix (Applied Biosystems)
and the ABI 7500 Fast instrument. Combined and endogenous levels of Oct4, Sox2, and Klf4 were distinguished by
primers designed at different regions. Data were analyzed
using the 7500 software version 2.0.2 provided with the
instrument. Quantification was normalized to the endogenous glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
as the internal control and relative mRNA expression was
calculated using R1-ESC as the reference.

Statistical analysis
Data were analyzed using one-way ANOVA with Tukey’s multiple comparisons or Student’s t-test. All experiments were performed at least twice (N ‡ 2). Values in
figures are presented as mean – standard deviation (SD). A P
value < 0.05 (*) or < 0.01 (**) was considered statistically
significant.

Results
Knockdown of Brm or Baf170 at different stages
promotes reprogramming
To investigate the roles of Brm and Baf170 in reprogramming and differentiation, we first measured their
mRNA levels in OG-MEFs, OG-MEF-derived iPSC clones,
OKM-reprogrammed pre-iPSCs, and R1-ESCs. The levels
of mRNAs for Brm and Baf170 in OG-MEFs and in preiPSCs were five to eight times higher than those in iPSCs
and R1-ESCs (Fig. 1A). We further found that subunits of
esBAF (Baf60a, Baf200, Baf250a, Brg1, and Baf155) were
upregulated in iPSCs and R1-ESCs compared with OGMEFs and pre-iPSCs (Supplementary Fig. S2), suggesting
that the BAF complex undergoes subunit changes while
cells transit from differentiated to pluripotent states. Wes-
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tern blot analyses also revealed a dramatic higher level of
proteins for Brm and Baf170 in OG-MEFs and pre-iPSCs
than those in iPSCs and R1-ESCs (Fig. 1D). The inverse
correlation between Brm, Baf170, and the state of differentiation, especially in partially reprogrammed pre-iPSCs,
suggests that Brm and Baf170 may interfere with somatic
reprogramming. We then asked whether knocking down
Brm or Baf170 would improve reprogramming. Using lentiviral shRNA constructs designed specifically against either
Brm or Baf170, we were able to knock down Brm and
Baf170 mRNA levels in OG-MEFs by more than 95% (Fig.
1B, C, and Supplementary Fig. S3A, B), which were also
confirmed at protein levels by western blot analyses (Fig.
1E, F). We then reprogrammed OG-MEFs with OKSM (day
0) in the presence of shBrm or shBaf170 or shCtl on day 3
and cultured the cells in 2i/LIF medium. Two weeks after
OKSM induction, dome-shaped ESC-like GFP+ colonies
started to appear in all treatment groups. Knocking down of
Brm resulted in a significant increase in GFP+ colonies
compared with controls (Fig. 1G). On the contrary, knocking down Baf170 had minimal impact on GFP+ colony
formation (Fig. 1G). To further dissect the effect of somatic
BAF components on reprogramming, we knocked down
Brm and Baf170 at later stages, that is, on day 6 or 9. Interestingly, similar results were obtained when treatments
were given on day 6 (Fig. 1H), while knocking down Baf170
on day 9 produced a significant gain on reprogramming
efficiency (Fig. 1I). Collectively, these observations demonstrate that Baf170 inhibits reprogramming at a later stage,
while removal of Brm at any stage improves reprogramming
(Fig. 1G–I).
Subsequently, we characterized the GFP+ colonies (Fig.
2A) for their reprogramming status. Interestingly, we found
that the colonies induced by shBrm were significantly
smaller than those treated with shBaf170 or shCtl (Fig. 2B).
Furthermore, we observed that GFP+ colonies induced by
shBrm and shBaf170 shared the following properties with
the control ESC line, R1: (1) formation of tight compact
colonies with strong AP activity (Fig. 2C); (2) propagation
in 2i/LIF medium and positive immunostaining for pluripotent genes and surface markers, including Oct4, Sox2, and
SSEA1 (Fig. 2D); and (3) formation of EBs in vitro (Fig.
2E) and differentiation to cells expressing markers of the
three germ layers (data not shown). Of note, no differences
were found in the numbers of AP, Sox2, Oct4, and SSEA1positive colonies or EBs between shBrm or shBaf170 and
shCtl-treated cells expect for a slightly smaller EB size in
shBrm and shBaf170-treated cells. The reprogramming was
also relatively complete because the retroviral transgenes
were virtually silenced in the induced iPS colonies (Fig. 2F).
Taken together, the above data demonstrate that inhibition
of Brm or Baf170 is critical for efficient reprogramming in a
stage-specific manner.

Knockdown of Brm or Baf170 promotes complete
reprogramming of pre-iPSCs
Because we had determined that knockdown of Brm and
Baf170 is critical for efficient late-stage reprogramming of
OG-MEFs, and also Brm and Baf170 were highly expressed
in pre-iPSCs (Fig. 1A, D), we asked whether their inhibition
is also required for the complete reprogramming of these
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FIG. 1. Knockdown of Brm or Baf170 promotes reprogramming in a stage-specific manner. (A) The levels (mean – SD) of
Brm and Baf170 mRNAs are low in induced pluripotent stem cells (iPSCs) and murine embryonic stem cells (R1-ESCs), but
high in OG-MEFs, pre-iPSCs induced by ectopic Oct4/Klf4/c-Myc (OKM) infection (n = 3). The OG-MEFs are mouse
embryonic fibroblasts harboring the green florescence protein (GFP) driven by the Oct4 promoter. Transfection of OGMEFs with lentiviruses expressing different small hairpin RNAs against Brm (shBrm; B) and Baf170 (shBaf170; C) reduced
Baf170 and Brm by 95% and 96%, respectively. (D) Western blots showing the protein levels of Baf170 and Brm in OGMEFs, Pre-iPSCs, iPSCs, and R1-ESCs. Both Baf170 and Brm are present in OG-MEFs and Pre-iPSCs, while nearly absent
in iPSCs and R1-ESCs. GAPDH was used as the loading control. Transfection of OG-MEFs with shBrm (E) and shBaf170
(F) efficiently reduced the protein levels of Brm and Baf170, respectively. Knocking down Brm on day 3 (G), day 6 (H), and
day 9 (I) and knocking down Baf170 only on day 9 (I) significantly increased the numbers of GFP+ colonies (mean – SD)
induced by OKSM (**P values < 0.01; n = 3).

cells. We knocked down Brm and Baf170 in two stable preiPS cell lines from our previous study [16] and found that
suppressing Brm and Baf170 increased the numbers of GFP+
colonies by 5.5- and 11-fold, respectively, compared with
controls (Fig. 3A). Similarly, FACS analysis showed that
reduced Brm and Baf170 resulted in 49.1% and 70.6% GFP+
cells, respectively, compared with controls (5.57%; Fig.
3B). Characterization of GFP+ colonies from the treated preiPSCs demonstrated that these colonies grew readily in 2i/
LIF medium, maintained bright GFP expression and ESClike colony morphology under repeated passaging, stained
positive for AP activity, and expressed ESC-specific gene
markers, such as Oct4, Sox2, Nanog, and SSEA1 (data not
shown). These data corroborated with those in OG-MEF
reprogramming that inhibition of either Brm or Baf170 efficiently converted pre-iPSCs to iPSCs, while Baf170
knockdown at this late stage of reprogramming is more effective than Brm knockdown.

Knockdown of Brm or Baf170 promotes
reprogramming by activating the pluripotency
circuitry
As depletion of Brm or Baf170 enhanced reprogramming
efficiency and promoted complete late-stage reprogramming, we sought to investigate the mechanisms of these
effects by examining the expression of ESC/iPSC-specific
genes. We found that early removal of Baf170 (days 3 and
6) did not affect the expression of core pluripotency genes
(Fig. 4A, B), while knockdown of Baf170 on day 9 resulted
in significant upregulation of Sox2, Nanog, Esrrb, and Tbx3
(Fig. 4C). On the contrary, inhibiting Brm at any stage of
reprogramming significantly increased the expression of
Nanog, Esrrb, and Tbx3 (Fig. 4A–C). Brm inhibition also
elicited stage-specific upregulation of pluripotent genes. For
example, Oct4 and Rex1 were induced on day 3, Sox2 on
day 6, and Sox2 and Klf4 on day 9. Additionally, we also

FIG. 2. Cells reprogrammed by OKSM and Brm- or Baf170-knockdown are pluripotent. (A) Representative iPSC colonies
(passage 5) induced by OKSM plus shBrm or shBaf170 and cultured in 2i/LIF medium. The GFP+ colonies indicate
activation of the internal Oct4 gene (scale bar = 250 mm). The average size of colonies (areas; mean – SD) induced by shBrm
is significantly smaller than that by shBaf170 and shCtl (B) (**P values < 0.01; n = 3). The induced colonies stained strongly
for AP (C; passaged 5) and pluripotency markers, including SSEA1, Oct4, and Sox2 (D; scale bar = 25 mm; passage 6). The
induced colonies also formed EBs after 7 days of differentiation (E; scale bar = 250 mm). Nuclei of the cells were counterstained with DAPI. All GFP+ colonies induced by shBrm and shBaf170 shared similar properties with the control R1ESCs. (F) Similar levels of combined and endogenously (Oct4*, Sox2*, and Klf4*) expressed transcription factors in
OKSM-infected OG-MEFs also transfected with shBaf170 or shBrm were observed in the reprogrammed cells, suggesting
that the exogenous induction factors were silenced. Values were normalized with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and relative to R1-ESCs (n = 3).

FIG. 3. Knocking down Brm or Baf170 promotes complete reprogramming of pre-iPSCs. The numbers of GFP+ colonies
(mean – SD; A) significantly increased 10 days after pre-iPSCs were infected with shBrm or shBaf170. Mean values of three
independent experiments from two pre-iPS cell lines are shown (**P values < 0.01; n = 3). The reprogrammed colonies
contained different percentages of GFP+ cells as analyzed by fluorescence-activated cell sorting (B; n = 2).
2332
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FIG. 4. Knocking down Brm or Baf170 promotes reprogramming by activating the pluripotency circuitry. Relative levels
of mRNA for selected ESC-specific genes in OG-MEFs transfected with shBaf170, shBrm, or shctl on day 3 (A), day 6 (B),
and day 9 (C) of OKSM reprogramming. Oct4*, Sox2*, and Klf4* represent mRNA expressed endogenously. Values were
normalized with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and relative to shCtl (*P values < 0.05; n = 3). (D)
Relative levels of mRNA for selected ESC-specific genes in pre-iPSCs 10 days after transfection with shBaf170, shBrm, or
shCtl (n = 3). Results were normalized with GAPDH and relative to shCtl.

showed that Sox2, Nanog, Rex1, Esrrb, and Tbx3 were
significantly upregulated when Brm and Baf170 were inhibited in pre-iPSCs (Fig. 4D). Taken together, these results
demonstrated that inhibition of Brm or Baf170 promotes
reprogramming efficiency by activating the pluripotency
circuitry in a stage-specific manner.

Inhibition of Brm or Baf170 promotes Jak/Stat3
signaling during complete reprogramming
It has been reported that esBAF facilitates pluripotency
by conditioning the genome for LIF/Stat3 signaling [11].
We have also shown that Jak/Stat3 signaling plays an essential role in epigenetic regulation of late-stage somatic
cell reprogramming [16]. In this study, we sought to determine if somatic BAF components are involved in the intricate interplay of Stat3 signaling during reprogramming.
We analyzed Stat3 mRNA transcripts 10 days after shBrm
or shBaf170 transduction of pre-iPSCs. Interestingly, we
found that expression of Stat3 was significantly increased by
inhibiting Brm or Baf170 in pre-iPSCs (Fig. 5A). We further
revealed that knockdown of Brm or Baf170 significantly
stimulated the expression of Socs3—the direct target of
Stat3 (Fig. 5A). These results suggest that the presence of
Brm and Baf170 inhibited the Stat3 pathway during reprogramming.

Retroviral silencing is a prerequisite for pluripotency
establishment in retroviral transgene-mediated reprogramming and is achieved by de novo DNA methylation through
DNA methyltransferases (Dnmts) 3a, 3b, and Dnmt3L [16–
20]. We have also shown previously that Jak/Stat3 activity
facilitates Dnmt3L expression. This, in turn, stimulates de
novo DNA methylation, which silences retroviral transgenes
and possibly lineage commitment genes [16]. Examining the
expression of Dnmts here revealed that Brm and Baf170
knockdown drastically increased the expression of de novo
methyltransferase Dnmt3a and 3L (Fig. 5B). These results
suggested that reducing somatic Brm or Baf170 stimulates
de novo DNA methylation, which is correlated with the
elevated Stat3 pathway. Therefore, somatic BAF reduction
may coordinate with the Stat3-regulated epigenetic network
for pluripotency establishment.
To further dissect the intricate interplay of Brm/Baf170
and Jak/Stat3 signaling, we examined whether inhibiting
Jak/Stat3 would affect Brm and Baf170. We reprogrammed
OG-MEFs and cultured them with either DMSO control or a
low dosage (1 mM) of the reversible Jak inhibitor I ( Jaki),
starting on day 3 of reprogramming. Jaki treatment virtually
blocked the formation of all GFP+ colonies; however, this
did not change the number of GFP-negative colonies formed
(data not shown). Furthermore, mRNAs for components of
esBAF, Baf60a, Baf250a, Brg1, Baf155, Baf47, Baf200,
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FIG. 5. Inhibition of Brm or Baf170 promotes Jak/Stat3 signaling during complete reprogramming. Relative levels of
mRNA for (A) Stat3 and its direct target, Socs3, as well as do novo Dnmts (B) in pre-iPSCs 10 days after being transfected
with shBaf170 or shBrm. Results were normalized with GAPDH and related to shCtl (**P values < 0.01; n = 3). (C) Relative
levels of mRNA for different subunits of the BAF complex in OG-MEFs, R1-ESCs, and OKSM-transduced OG-MEFs 18
days after initial OKSM viral transduction. The reprogrammed cells were treated with either DMSO or 1 mM Jaki. Results
were normalized with GAPDH and relative to those in R1-ESCs (*P values < 0.05; n = 3). (D) Relative levels of mRNA for
Brm and Baf170 in OG-MEFs, R1-ESCs, and passage two (P2) of reprogrammed cells. The reprogrammed cells were
treated with either DMSO or 1 mM Jaki. Results were normalized with GAPDH and relative to those in R1-ESCs (*P
values < 0.05; n = 3).
Baf60b, and Baf57, were consistently expressed and unchanged, while the somatic BAF components, Brm and
Baf170, were significantly upregulated in Jaki-treated cells
compared with DMSO-treated control cells (Fig. 5C). To
minimize the heterogeneity of cells in the analysis, three
typical colonies from each treatment were collected 3 weeks
after viral transduction and analyzed for their gene expression at passage 2 (P2). A dramatic upregulation of mRNAs
for Brm and Baf170 was consistently observed in Jakitreated cells compared with the DMSO controls (Fig. 5D).
Thus, a positive feedback loop exists between Jak/Stat3 and
the inhibition of Brm and Baf170 during ground-state pluripotency establishment.

Discussion
iPSCs can be generated from somatic cells by ectopic
expression of transcription factors, such as Oct4, Sox2, Klf4,
and Myc (OKSM) [1], but the efficiency remains low. A
variety of chromatin modifiers, such as Brg1/Baf155, Utx,
and MBD3/NuRD, have been implicated in facilitating epigenetic changes leading to authentic iPSC reprogramming
[12,21–24]. In this study, we identified a negative role by
Brm and Baf170 on OKSM-mediated reprogramming of
OG-MEFs. We found that shRNA-mediated knockdown of
Brm or Baf170 led to an increase in reprogramming effi-

ciency. Specifically, Baf170 seems to be more inhibitory to
reprogramming at the late stage when the pluripotency
network is becoming more stably established, while Brm
inhibits reprogramming at all phases. In addition, it is interesting to note that colonies induced by Brm knockdown
were significantly smaller than those from Baf170 knockdown. Sizes of ES colonies and EBs have been shown to
affect their differentiation trajectories [25] through different
gradients of signaling molecules [26]. The size difference
observed may reflect a mechanism that cells employ to
regulate their fates upon changes of BAF compositions.
Components of esBAF have been shown to be important
in both maintenance of mESCs and iPSC induction. Deficiency in Brg1, Baf47, Baf155, or Baf250 impaired the
ability of mESCs to proliferate and to maintain pluripotency
[8–11,27,28]. Brg1 and Baf155, combined with Oct4, Sox2,
Klf4, and c-Myc, can synergistically increase reprogramming efficiency [12]. Because iPSCs have similar properties
with ESCs, it is logical to infer that homologs of Brg1 and
Baf155 and Brm and Baf170 obstruct reprogramming, which
was proven in the current study. Our results are also in
agreement with the recent finding that levels of Brm increase
during differentiation of ESCs [10]. Moreover, the dynamic
composition of BAF seems to correlate with the differentiation status of the cells, that is, Baf170 is more important in
differentiated cells, whereas Baf155 is more important in
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undifferentiated ES cells [8,10]. Competition between
Baf170 and Baf155 subunits within the BAF complex was
also observed during progression of neurogenesis and affected euchromatin structure and thereby modulated the
binding efficiency of their targets [29]. Our results expanded
this notion that the BAF complex undergoes subunit changes while cells transit from differentiated to pluripotent
states, that is, acquisition of esBAF and disposition of the
somatic BAF components (Brm and Baf170). Moreover, it
suggested that somatic BAF inhibits the formation of esBAF
and therefore serves as a barrier during reprogramming.
We discovered that removal of Brm and Baf170 aids in
full reprogramming. At selective loci, pre-iPSCs and somatic cells possess similar chromatin structures, which are
condensed and arrested epigenetically during reprogramming [30,31]. Pre-iPSCs can be completely reprogrammed
to pluripotency by overexpressing Sox2 or Nanog [32]. The
pre-iPSC stage is an epigenetically stable landmark along
the journey of reprogramming and these cells can progress
toward the authentic iPSCs through the removal of epigenetic determinants for the intermediate state [31]. In this
study, we provide a new insight that the presence of the
somatic Brm and Baf170 is a potential epigenetic barrier
during reprogramming. First, high levels of both Brm and
Baf170 are present in pre-iPSCs. Second, knockdown of
Brm or Baf170 upregulated the expression of pluripotencyrelated core transcription factors, such as Sox2, Nanog,
Rex1, Tbx3, and Esrrb, suggesting that the somatic BAF
complex may be inhibitory to the expression of pluripotency-related genes. Interestingly, during mouse somatic
reprogramming, Brg1 and Baf155 were recruited by Oct4 to
relax chromatin structure and facilitate the binding of other
transcription factors that enhance reprogramming [12].
Genome-wide colocalization of Brg1 with Oct4, Sox2, and
Nanog [27,33] further suggests that the somatic components
of BAF are not compatible with reprogramming.
An important contribution of this study was to provide
evidence that the suppressed Brm and Baf170 may coordinate with the Stat3-regulated epigenetic network during
pluripotency establishment. Activation of the Jak/Stat3
signal pathway is essential for maintaining mESC pluripotency [34] and for reactivating the endogenous pluripotency network in somatic cells [16,35]. Although the role
of the SWI/SNF complex in Stat3 signaling was discovered
previously, the finding was only limited for Brg1 [11,36,37].
More recently, binding sites of Stat3 and esBAF had been
shown to frequently overlap in the ESC genome [8,27].
Moreover, Ho et al. [11] provided evidence that esBAF is
required to establish chromatin accessibility at Stat3 binding
targets and to prepare these sites to respond to LIF signaling,
therefore allowing in vitro preservation of ground-state
pluripotency. These studies established a strong connection
between the esBAF complex and Stat3 activities. For the
first time, we demonstrated here a link between Brm,
Baf170, and Stat3 activities. We not only showed that
knocking down Brm and Baf170 stimulated Stat3 activity
but also inhibiting Jak/Stat3, in turn, increased the expression of Brm and Baf170 during reprogramming, thus revealing an interplay between Stat3 and somatic BAF during
reprogramming. In addition, we demonstrated that reducing
somatic Brm and Baf170 drastically increased the expression of de novo methyltransferase Dnmt3a and 3L. These
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changes were also seen when the Stat3 pathway was activated [16]. Therefore, Brm and Baf170 inhibition integrates
in the Stat3-regulated epigenetic network for pluripotency
establishment. Our results provide new insights that Stat3
may promote esBAF formation by inhibiting somatic BAF.
As Stat3 activation is key to ground-state pluripotency establishment during somatic cell reprogramming [16], our
data here indicate that inhibiting Brm and Baf170 coordinates with the determining effects of Stat3 in pluripotency
establishment, and a mutually suppressive interaction between Stat3 and somatic BAF is one of the mechanisms
involved.
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